Independent Supplier Analysis from PeptideBond

The largest compounding operation in the US with both 503A and 503B facility designations. They ship nationwide with a deep peptide catalog — Semaglutide, Tirzepatide, GHK-Cu, and most compounds that are currently Category 1 eligible. Their 503B status means they can produce without patient-specific prescriptions for office use, which is a significant advantage for clinics ordering at volume. Pricing runs higher than smaller pharmacies, but the compliance documentation is thorough and holds up during FDA inspections.

Established compounding pharmacy with a strong focus on peptide therapy and bioidentical hormone replacement. They work directly with prescribers and have built a reputation in the integrative medicine community for reliable formulations and responsive clinical support. Their educational resources for practitioners are a differentiator — they invest in helping clinics understand what they're prescribing.

Florida-based compounder with a broad wellness and peptide catalog. They serve a mix of anti-aging clinics, telehealth platforms, and individual practitioners. Turnaround times are competitive, and they've been expanding their peptide offerings as FDA reclassification opens up more compounds. Solid option for clinics in the Southeast looking for a regional compounder with national reach.

Peptide-focused compounder that's built a loyal following among regenerative medicine clinics. Strong customer service reputation — they're known for walking clinics through product options and explaining formulation differences. They've invested in quality compound production and maintain close relationships with their prescriber network. Good fit for practices that want a more hands-on pharmacy partner.

Currently one of the most widely recommended research peptide vendors in the US. They carry a broad catalog with batch-specific COA testing and publish results for each lot. Same-day shipping on most orders and a 30-day money-back guarantee. Their product range extends beyond peptides into nootropics and health optimization compounds. Not GMP — this is research-grade material for laboratory use only.

Newer entrant that's built a strong reputation quickly. They emphasize advanced synthesis technology and claim purity levels exceeding 99% verified through HPLC. Competitive pricing, fast US shipping, and a growing catalog of popular research peptides including BPC-157 and TB-500. Still building their long-term track record, but early indicators and community feedback are positive.

San Diego-based vendor with one of the larger injectable peptide catalogs — 87+ products at last count. They accept standard payment methods and provide third-party testing documentation. A reliable option for researchers who need variety, though they face increasing competition from newer vendors with more aggressive pricing and differentiation.